SARA HARDY: Open Payments
NPI 1447848916 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 22 payments from 11 companies in 2025. Trend: 2023 $793 · 2024 $627 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $77 |
| Novo Nordisk Inc | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| ABBVIE INC. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Lundbeck LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: JARDIANCE, VRAYLAR, NURTEC ODT, LEQVIO, Ozempic, Wegovy, REXULTI, MOUNJARO.
Industry payments across NC — which companies pay providers there.
